Heamodynamic Doppler changes in portal pressure after trans-arterial chemoembolization of hepatocellular carcinoma.

Heamodynamic Doppler changes in portal pressure after trans-arterial chemoembolization of hepatocellular carcinoma.

Aim: The goal of this study was to determine changes in portal pressure hemodynamics of HCC patients after their management using transarterial chemoembolization (TACE). Twenty five patients with HCC underwent TACE. Medical history in addition to investigations were carried out including Doppler ult...

Full description

Bibliographic Details
Main Authors:	Yasmine Ali, Ahmed Mohammed, Faten Ali
Format:	Article
Language:	English
Published:	Beni-Suef University, Faculty of Medicine 2022-01-01
Series:	Egyptian Journal of Medical Research
Subjects:	portal hypertension hcc doppler ultrasound tace
Online Access:	https://ejmr.journals.ekb.eg/article_226200_213294a0e24ecc98723b0f402d15c970.pdf

Similar Items

Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure
by: Constantine Frangakis, et al.
Published: (2021-11-01)

Transradial approach for transarterial chemoembolization of hepatocellular carcinoma in Egyptian patients: Initial study
by: Mohamed El-Gharib, et al.
Published: (2016-09-01)

Role of diffusion weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to trans-arterial chemoembolization
by: Rasha Mahmoud Gomaa, et al.
Published: (2021-06-01)

Subtraction MRI versus diffusion weighted imaging: Which is more accurate in assessment of hepatocellular carcinoma after Trans Arterial Chemoembolization (TACE)?
by: Noha Abd ElShafy ElSaid, et al.
Published: (2016-12-01)

Transcatheter Arterial Chemoembolization with Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma: Recommended Selection for Small-Caliber (<100 μm) Beads
by: Chang WC, et al.
Published: (2021-08-01)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
by: Kylie E. Zane, et al.
Published: (2021-10-01)

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2017-07-01)

Role of portal color Doppler ultrasonography as noninvasive predictive tool for esophageal varices in cirrhotic patients
by: Mohamed Alaa ELdin Nouh, et al.
Published: (2022-01-01)

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
by: Christine Koch, et al.
Published: (2021-04-01)

Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
by: Asahiro Morishita, et al.
Published: (2021-09-01)

Can triphasic hepatic multislice CT validate the LI-RADS treatment response algorithm after trans-catheter arterial chemoembolization treatment of hepatocellular carcinoma?
by: Hany El-Assaly, et al.
Published: (2023-01-01)

Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
by: Chengjian He, et al.
Published: (2022-06-01)

Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study
by: Qinghe Tang, et al.
Published: (2021-07-01)

PORTAL VEIN THROMBOSIS-ULTRASOUND IMAGING
by: Trajkovska Meri, et al.
Published: (2016-07-01)

Hipertensão portal esquistossomótica avaliação do fluxo sangüíneo portal antes e após tratamento cirúrgico
by: Antônio Alves Júnior, et al.

The value of dynamic subtraction MRI technique in the assessment of treatment response of hepatocellular carcinoma to transcatheter arterial chemoembolization
by: Lamiaa I. A. Metwally, et al.
Published: (2019-09-01)

Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma
by: Seiichi Mawatari, et al.
Published: (2022-12-01)

Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization
by: Salma Binzaqr, et al.
Published: (2023-12-01)

Ultrasound and Doppler examination capabilities in adult portal hypertension type definition
by: N. V. Tumanskaya, et al.
Published: (2015-08-01)

Relationship between M6A methylation regulator and prognosis in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
by: Deliang Huang, et al.
Published: (2022-10-01)

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
by: Maria Tampaki, et al.
Published: (2020-01-01)

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients
by: Jing-huan Li, et al.
Published: (2021-08-01)

Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
by: Aoran Dong, et al.
Published: (2023-12-01)

Role of diffusion-weighted magnetic resonance imaging in the evaluation of hepatocellular carcinoma response to transcatheter arterial chemoembolization using drug eluting beads; correlation with dynamic MRI
by: Mohamed I. Yousef, et al.
Published: (2017-12-01)

Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma
by: Hongfa Sun, et al.
Published: (2023-03-01)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
by: Jia Deng, et al.
Published: (2023-01-01)

Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis
by: Jian Qin, et al.
Published: (2022-04-01)

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres® Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
by: Xuhua Duan, et al.
Published: (2022-01-01)

Intra-arterial chemoembolization with hepasphere 50–100 μm for patients with unresectable hepatocellular
by: Talal Amer, et al.
Published: (2015-12-01)

PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis
by: Li H, et al.
Published: (2023-07-01)

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
by: Lei Zhang, et al.
Published: (2021-08-01)

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
by: Alessandro Rizzo, et al.
Published: (2022-10-01)

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
by: Sven H. Loosen, et al.
Published: (2019-10-01)

Role of 18-FDG/PET in evaluation of hepatocellular carcinoma managed locally by transarterial chemoembolization compared to triphasic computed tomography
by: Manal Ibraheim Gomaa
Published: (2020-07-01)

Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
by: Yao Hongjuan, et al.
Published: (2020-12-01)

Standards of the Polish Ultrasound Society. Ultrasound examination of the portal system and hepatic vessels
by: Robert Lechowicz, et al.
Published: (2015-06-01)

Effect of prophylactic transcatheter arterial chemoembolization on hepatocellular carcinoma with microvascular invasion after R0 resection. A case-control study
by: Ke-Yue Li, et al.
Published: (2020-04-01)

The association between character of portal blood flow and post-TIPS incidence of hepatic encephalopathy
by: Helmy El-Shazly, et al.
Published: (2020-08-01)

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization
by: Naoshi Odagiri, et al.
Published: (2020-07-01)

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)